Indian stock market is expected to maintain its upward momentum, targeting Nifty 50 at 28,700 level. However, this upward ...

Stocks including UltraTech Cement, Reliance Industries, Tata Consultancy Services, NTPC Green, Indian Oil, Aurobindo Pharma, ...

a subsidiary company of Laurus Labs. The company completed the said transaction on December 20. The Competition Commission of ...

Laurus Labs Ltd today announced that its subsidiary, Laurus Bio, has signed a definitive agreement for an equity investment ...

Catch up on the latest stock market news! Today, we cover key developments including Aurobindo Pharma’s marketing authorization for its biosimilar, Fortis Healthcare's stake acquisition in Agilus ...

Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected ...

The Nifty Pharma index closed on a positive note on Monday. ET Year-end Special Reads Gold outshines D-St with 20% returns, ...

Outlook 2025: The “buy on dips” strategy has been effective in the Indian stock market and Bajaj Broking recommends continuing this approach by selectively accumulating quality stocks.(Image ...

J B Chemicals & Pharmaceuticals Ltd.(down 1.8 per cent), Torrent Pharmaceuticals Ltd.(down 0.57 per cent), Ajanta Pharma Ltd.